Metrology for innovative nanotherapeutics
The uptake of the developed protocols and reference materials candidates, and alignment with industry beyond the consortium will be promoted through early engagement with additional industrial end users belonging to (i) the pharmaceutical industry and the medical device industry, (ii) SMEs that are members of the main European nanomedicine associations and (ii) instrument providers.
Importantly, the ETPN (European Nanomedicine Technology Platform) will lead the impact work package, addressing the whole European nanomedicine community, and benefitting from its well established network and methodology for community building and common strategic thinking.
Dr. Alexandre Ceccaldi
General Secretary –ETPN
Short bio: Alexandre Ceccaldi, General Secretary of the European Technology Platform on Nanomedicine (ETPN), holds a PhD in Biology from University Pierre and Marie Curie in Paris, and an engineering degree from Agro ParisTech. His expertise spans anticancer strategies, industrial management, and innovative design. He previously managed INGESTEM, a French consortium for induced pluripotent stem cell research. Since 2015, he has managed the ETPN Association, uniting 120 member institutions across Europe, representing all stakeholders from academia to large industry. He has coordinated the H2020 NOBEL Project and helped to establish the pioneering HealthTech4EU Alliance, acting for the convergence of all emerging health technologies in Europe. In 2023, he joined the Strategic Advisory Board of the ERA4HEalth funding programme